Navigation Links
Defining the Value of Medicine in an Evidence-Based Healthcare Marketplace
Date:11/26/2007

Thought-leaders Josh Ofman, Steve Phurrough, Larry Kocot and Robert Seidman Headline Agenda at FDA/CMS Summit 2007

WASHINGTON, Nov. 26 /PRNewswire-USNewswire/ -- Value-based medicine has progressed beyond a topic of industry insider buzz to become a functional buying model adopted by public and private payers. Value isn't a new concept in the consumer marketplace, but what does it mean for buying and selling biopharmaceuticals? How is value calculated, and what are the variables? From setting prices to securing reimbursement, the valuation of treatments is tougher than ever to crack. And the stakes have never been higher with shrinking pipelines and tighter bottom lines. Getting the value calculation right can be the difference between success and failure of a new therapy.

(Logo: http://www.newscom.com/cgi-bin/prnh/20071126/DC08207 )

The FDA/CMS Summit, taking place December 6-7 in Washington, D.C., will feature key decision makers from government and industry to help biopharmaceutical executives understand how the value calculation is shifting, and what those changes mean for commercial success.

"Today, the value of a therapy is determined by more players than ever before, looking at more data than ever before. The threshold is a moving target for biopharmaceutical executives seeking reimbursement," said Cole Werble, editor-in-chief of The RPM Report, the conference organizer. "Learning what payers are looking at when making decisions early on can help industry come to market with successful products that are appropriately reimbursed. The FDA/CMS Summit provides leaders in industry key insight from reimbursement policy-makers who make purchasing and pricing decisions."

The FDA/CMS Summit provides health care executives with an exclusive opportunity to have face-to-face dialogues with top policymakers and executives. The Summit is aimed at industry executives in all areas of responsibility who want to create successful strategies for dealing with FDA and CMS. Attendees will get practical, real-life lessons from some of the most experienced pharmaceutical and biotechnology executives on handling regulatory obstacles and on identifying opportunities in the current dynamic environment. The conference will also provide a forum for attendees to benchmark their regulatory strategy against all other pharmaceutical and biotechnology companies.

Among the panels and participants scheduled to address value of medicine during the Summit are:
-- Personalized Medicine: How Industry and Government Can Make it Happen

George Abercrombie - CEO, Hoffmann La-Roche, Inc.

-- Keynote Address

Tevi D. Troy - Deputy Secretary, HHS

-- Paying for Innovation: CMS' Approach to Coverage

Steve Phurrough - CMS Coverage & Analysis Group Director

-- Coverage Policy and Value Demonstration - An Industry Perspective

Josh Ofman - VP Global Reimbursement, Amgen

-- How the Government and Payors will Impact the Rx Market

Larry Kocot - Former CMS Senior Advisor

Robert Seidman - Former Wellpoint Chief Pharmacy Officer and Founder

of Doc Rock Presents

-- Pharmaceutical Pricing Legislation: What does Industry Need to do to

Prepare?

Brian Cohen - House Oversight and Government Reform Committee Staff

Stephen Schondelmeyer, Pharm.D., Ph.D. - Director, PRIME Institute

Joseph R. Antos - Wilson H. Taylor Scholar on Health Care and

Retirement Policy, American Enterprise Institute

Complete agenda and registration information are available at http://www.windhover.com/fda-cms.

The RPM Report is a unique Windhover publication that examines FDA and CMS from a business perspective, designed to deliver not only the news from FDA and CMS but to tell executives what it all means to their companies. Register for a free online trial or a complimentary issue at http://www.rpmreport.com.

Sponsors for the FDA/CMS summit are Foley Hoag LLP, Ogilvy Public Relations Worldwide, Avalere Health, and the Personalized Medicine Coalition.

Media sponsors are pharmalicensing.com, and bioscreening.com.

About Windhover Information

Windhover Information Inc. has led the field in providing analysis of the healthcare industry to decision-makers at all levels since the founding of its flagship publication, IN VIVO, The Business & Medicine Report, in 1983. Windhover provides its information and analysis in many formats, including print, electronic databases, international conferences and audio conferences. For more on the company's products and services, please see http://www.windhover.com.


'/>"/>
SOURCE Windhover Information Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. ZIP codes and property values predict obesity rates
2. Elliott Extremely Dissatisfied With Genzyme Bid for Bioenvision; Believes Offer Significantly Undervalues Company
3. MaxLife Fund Corp. purchases a portfolio of Life Settlement Policies with a face value of $4,000,000
4. Cincinnati Adoption Agency Invited to Participate in Values Voter Presidential Debate
5. Study Questions Flu Shots Value for Older People
6. Glycemic index values are variable, report researchers
7. Medco Unveils Three New Medicare Prescription Drug Plan Options for 2008 to Provide Seniors More Choice, Better Value and Specialist Pharmacists
8. Boston Scientific Announces New Initiatives to Increase Shareholder Value
9. Value of Most Post-Traumatic Stress Treatments Uncertain
10. Joint Juice Helps America Hydrate Its Joints* With New High Value Coupon Offer
11. What is a critical lab value? it depends, Hopkins researchers find
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... , ... Apple Rehab Shelton Lakes , which specializes in the delivery ... as part of a disaster drill on October 3rd. , Apple Rehab participated with ... Manager, as well as the Connecticut Long Term Care Mutual Aid Plan (LTC-MAP). ...
(Date:10/13/2017)... ... October 13, 2017 , ... Yisrayl Hawkins, Pastor and Overseer ... one of the most popular and least understood books in the Holy Scriptures, Revelation. ... descriptions that have baffled scholars for centuries. Many have tossed it off as mere ...
(Date:10/12/2017)... , ... October 12, 2017 , ... ... services for healthcare compliance program management, will showcase a range of technology and ... for Assisted Living (NCAL) Convention and Expo to be held October 14–18, 2017 ...
(Date:10/12/2017)... ... October 12, 2017 , ... The American College of Medical Informatics (ACMI) will ... during the Opening Session of AMIA’s Annual Symposium in Washington, D.C. AMIA’s Annual ... F. Collen, a pioneer in the field of medical informatics, this prestigious award is ...
(Date:10/12/2017)... ... ... Leading pediatric oncology experts at Children’s National Health System will ... the International Society of Paediatric Oncology (SIOP) Oct. 12-15. Chaired by Jeffrey ... Disorders at Children’s National, and Stephen P. Hunger, M.D., Chief of the Division ...
Breaking Medicine News(10 mins):
(Date:10/12/2017)... , Oct. 12, 2017 West ... in innovative solutions for injectable drug administration, today announced ... the market opens on Thursday, October 26, 2017, and ... results and business expectations at 9:00 a.m. Eastern Time. ... or 253-336-8738 (International). The conference ID is 94093362. ...
(Date:10/11/2017)... CHICAGO , Oct. 11, 2017  Hill-Rom Holdings, ... its Aspen Surgical facility in Las Piedras, ... surgical scalpels and blades. ... confirmed that the facility sustained minor structural damage, temporary ... Hurricane Maria. Repairs have been completed, manufacturing operations have ...
(Date:10/5/2017)... Ill. , Oct. 5, 2017  In ... Association of Oral and Maxillofacial Surgeons (AAOMS) released ... opioids – to be used as a first-line ... pain. Recognizing ... the AAOMS White Paper "Opioid Prescribing: Acute and ...
Breaking Medicine Technology: